Cargando…

Beta-Blockers in the Prevention and Treatment of Ischemic Heart Disease: Evidence and Clinical Practice

Coronary artery disease (CAD) is the most prevalent cardiovascular disease characterized by atherosclerotic plaque buildup that can lead to partial or full obstruction of blood flow in the coronary arteries. Treatment for CAD involves a combination of lifestyle changes, pharmacologic therapy, and mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Omer, Patel, Murti, Tomdio, Anna N., Beall, Jeffrey, Jovin, Ion S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144413/ https://www.ncbi.nlm.nih.gov/pubmed/37124437 http://dx.doi.org/10.4103/heartviews.heartviews_75_22

Ejemplares similares

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Improving outcomes of percutaneous coronary interventions in patients with stable ischemic heart disease
por: Patel, Dhavalkumar B., et al.
Publicado: (2020)

Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients
por: Erickson, Marc, et al.
Publicado: (2021)

Investigating the effects of beta-blockers on circadian heart rhythm using heart rate variability in ischemic heart disease with preserved ejection fraction
por: Saleem, Shiza, et al.
Publicado: (2023)

Heart Rate and Cardiovascular Disease: An Alternative to Beta Blockers
por: Liang, Michael, et al.
Publicado: (2009)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

The homing of bone marrow stem cells is differentially activated in ischemic and valvular heart diseases and influenced by beta-blockers
por: Kristocheck, Melissa, et al.
Publicado: (2018)

Beta-blockers in cirrhosis: Evidence-based indications and limitations
por: Rodrigues, Susana G., et al.
Publicado: (2019)

The effect of beta-blockers in acute heart failure according to heart rate
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke
por: Zeng, Yuanyuan, et al.
Publicado: (2023)

Poor tolerance of beta-blockers by elderly patients with heart failure
por: Yanagisawa, Satoshi, et al.
Publicado: (2010)

Autonomic dysfunction and beta blocker therapy in Chagas heart disease
por: Bestetti, Reinaldo B, et al.
Publicado: (2013)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis
por: Jackson, Jeffrey L., et al.
Publicado: (2019)

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure
por: Iyngkaran, Pupalan, et al.
Publicado: (2016)

High dose insulin therapy, an evidence based approach to beta blocker/calcium channel blocker toxicity
por: Woodward, Christina, et al.
Publicado: (2014)

Preventive Effects of the Angiotensin-II Receptor Blocker on Atrial Remodeling in an Ischemic Heart Failure Model of Rats
por: Yoon, Namsik, et al.
Publicado: (2013)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure
por: von Haehling, Stephan, et al.
Publicado: (2009)

Beta-blockers and mechanical dyssynchrony in heart failure assessed by radionuclide ventriculography
por: Jones, K. A., et al.
Publicado: (2022)

Comparison of Medical Treatments According to the Characteristics of Idiopathic Premature Ventricular Contractions: Beta-blockers or Calcium Channel Blockers?
por: BAYCAN, Omer Faruk, et al.
Publicado: (2023)

Perioperative use of beta-blockers
por: Priebe, Hans-Joachim
Publicado: (2009)

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

Complete heart block in cardiac sarcoidosis reversed by corticosteroid therapy: time course of resolution
por: Tomdio, Anna, et al.
Publicado: (2021)

Clinical Impact of Beta-blockers in the Revascularization Era
por: Kang, Soo-Jin
Publicado: (2020)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease
por: Steg, Ph. Gabriel, et al.
Publicado: (2012)

The Impact of Treatment with Beta-Blockers upon Mortality in Chronic Heart Failure Patients
por: Taneva, Borjanka, et al.
Publicado: (2016)

Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives
por: Chourdakis, Emmanouil, et al.
Publicado: (2021)

Using machine learning to uncover heterogeneity of beta blocker response in heart failure
por: Tison, Geoffrey H.
Publicado: (2022)

Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
por: Liu, Baoshan, et al.
Publicado: (2023)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
por: Habel, Nicole, et al.
Publicado: (2023)

Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials
por: Al-Gobari, Muaamar, et al.
Publicado: (2013)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c0e1spij87flqd0c4sqru192nq